Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 2026-10-08 5-day change 1st Jan Change
16.62 CNY -0.84% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -0.84% -11.45%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.55B 1.13B 1B 937M 852M 1.6B 109B 1.62B 11.26B 4.4B 55.38B 4.23B 4.13B 178B P/E 2026 *
18.2x
P/E 2027 * 15.1x
Enterprise Value 8.05B 1.2B 1.07B 1B 908M 1.71B 116B 1.73B 12.01B 4.7B 59.07B 4.51B 4.41B 190B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.85x
Free-Float
51.96%
Yield 2026 *
2.07%
Yield 2027 * 2.96%
08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-27 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
25-10-29 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
25-10-24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
25-06-13 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
25-04-30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
1 day-0.84%
1 week-0.84%
Current month-0.84%
1 month-8.58%
3 months+5.66%
6 months-11.97%
Current year-11.45%
1 week 16.5
Extreme 16.5
17.28
1 month 16.38
Extreme 16.38
18.18
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
22.96
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-29
Director of Finance/CFO 51 2022-04-27
Corporate Officer/Principal 45 2020-10-26
Director TitleAgeSince
Chairman 63 2008-05-11
Director/Board Member 53 2019-12-24
Director/Board Member 51 2020-01-09
Date Insider Type Main position Quantity % Market Cap. Importance
5/24/23 Buy 3,000 0.0009%
5/23/23 Buy 1,000 0.0003%
9/4/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-0.84%-21.57%-9.08% 1.14B
-1.61%+1.72%+38.30%+106.93% 1,060B
-0.76%-0.84%+35.21%+62.70% 623B
+0.39%+4.81%+17.81%+83.77% 480B
-0.29%-0.99%+64.79%+37.06% 352B
-2.03%+1.06%+21.08%+42.16% 345B
-1.92%-0.29%+10.54%+33.20% 274B
-2.36%-1.16%-7.14%+8.68% 249B
-1.37%+0.04%+38.29%+52.33% 223B
+0.17%-0.27%+24.40%+96.82% 182B
Average -1.04%+0.11%+22.17%+51.46% 378.91B
Weighted average by Cap. -1.05%+0.58%+30.41%+68.80%

Financials

2026 *2027 *
Net sales 3.75B 559M 499M 465M 423M 795M 54.09B 803M 5.59B 2.19B 27.49B 2.1B 2.05B 88.4B 4.25B 634M 566M 528M 480M 903M 61.41B 912M 6.34B 2.48B 31.21B 2.38B 2.33B 100B
Net income 424M 63.18M 56.42M 52.64M 47.81M 89.97M 6.12B 90.85M 632M 247M 3.11B 237M 232M 10B 512M 76.38M 68.21M 63.63M 57.8M 109M 7.4B 110M 764M 299M 3.76B 287M 281M 12.09B
Net Debt 503M 74.95M 66.93M 62.44M 56.72M 107M 7.26B 108M 750M 293M 3.69B 281M 275M 11.86B 339M 50.52M 45.11M 42.08M 38.23M 71.94M 4.89B 72.64M 505M 198M 2.49B 190M 186M 8B
Projected Income Statement - Annual - Tianjin Ringpu Bio-Technology Co.,Ltd.
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
26-10-08 CN¥16.62 -0.84% 3,516,100
26-09-30 CN¥16.76 +1.58% 2,587,824
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Tianjin Ringpu Bio-Technology Co.,Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
16.62CNY
Average target price
21.45CNY
Spread / Average Target
+29.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Tianjin Ringpu Bio-Technology Co.,Ltd.
  1. Stock Market
  2. Stocks
  3. 300119 Stock